Deal snapshot: Haemonetics to Acquire OpSens for USD 253m.

MANews-(C)2009-2023

Boston-based medical technology company Haemonetics Corp. (NYSE: HAE) has agreed to acquire Canada-based cardiology-focussed medical device company OpSens, Inc. (TSC: OPS) OTCQX; OPSSF) in an all-cash transaction representing a value of approximately USD253 m, the company said.

OpSens offers...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT